These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2187704)

  • 1. Muscarinic receptor subtypes in rat pancreatic islets: binding and functional studies.
    Verspohl EJ; Tacke R; Mutschler E; Lambrecht G
    Eur J Pharmacol; 1990 Mar; 178(3):303-11. PubMed ID: 2187704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic receptor subtypes in human and rat colon smooth muscle.
    Gómez A; Martos F; Bellido I; Marquez E; Garcia AJ; Pavia J; Sanchez de la Cuesta F
    Biochem Pharmacol; 1992 Jun; 43(11):2413-9. PubMed ID: 1610405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD; Mash DC
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]N-methylscopolamine binding studies reveal M2 and M3 muscarinic receptor subtypes on cerebellar granule cells in primary culture.
    Alonso R; Didier M; Soubrie P
    J Neurochem; 1990 Jul; 55(1):334-7. PubMed ID: 2355226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes.
    Waelbroeck M; Camus J; Tastenoy M; Feifel R; Mutschler E; Tacke R; Strohmann C; Rafeiner K; Rodrigues de Miranda JF; Lambrecht G
    Br J Pharmacol; 1994 Jun; 112(2):505-14. PubMed ID: 8075869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of thiol groups, calcium, and glucose metabolism on cholinergic-induced insulin release and on methylscopolamine binding to muscarinic receptors in pancreatic islets of the rat.
    Grill V; Fåk K
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):355-60. PubMed ID: 2411095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of muscarinic receptors in dog tracheal smooth muscle cells.
    Yang CM
    J Auton Pharmacol; 1991 Feb; 11(1):51-61. PubMed ID: 2030109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB; Eubanks JH; Creese I
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of glucagon-like peptide-1 secretion by muscarinic agonist in a murine intestinal endocrine cell line.
    Abello J; Ye F; Bosshard A; Bernard C; Cuber JC; Chayvialle JA
    Endocrinology; 1994 May; 134(5):2011-7. PubMed ID: 8156901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine.
    Giraldo E; Micheletti R; Montagna E; Giachetti A; Viganò MA; Ladinsky H; Melchiorre C
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1016-20. PubMed ID: 3252019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.
    Waelbroeck M; Tastenoy M; Camus J; Christophe J
    Mol Pharmacol; 1990 Aug; 38(2):267-73. PubMed ID: 2385234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
    Smith TD; Annis SJ; Ehlert FJ; Leslie FM
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
    Cortés R; Probst A; Tobler HJ; Palacios JM
    Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic receptor subtypes on rat pancreatic acini: secretion and binding studies.
    Louie DS; Owyang C
    Am J Physiol; 1986 Aug; 251(2 Pt 1):G275-9. PubMed ID: 2426974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites.
    Delmendo RE; Michel AD; Whiting RL
    Br J Pharmacol; 1989 Feb; 96(2):457-64. PubMed ID: 2924085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic receptors in pancreatic islets of the rat. Demonstration and dependence on long-term glucose environment.
    Grill V; Ostenson CG
    Biochim Biophys Acta; 1983 Mar; 756(2):159-62. PubMed ID: 6338932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic responses of gastric parietal cells.
    Wilkes JM; Kajimura M; Scott DR; Hersey SJ; Sachs G
    J Membr Biol; 1991 Jun; 122(2):97-110. PubMed ID: 1895339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini.
    Korc M; Ackerman MS; Roeske WR
    J Pharmacol Exp Ther; 1987 Jan; 240(1):118-22. PubMed ID: 2433426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and binding studies with muscarinic M2-subtype selective antagonists.
    Lazareno S; Roberts FF
    Br J Pharmacol; 1989 Sep; 98(1):309-17. PubMed ID: 2804551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.